This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Maka...
Johnson & Johnson released new data suggesting its lung cancer combination Rybre...
Wave Life Sciences shared updated results from a Phase 2 trial of its exon-skipp...
One of the biotech industry's most well-funded cell and gene therapy companies h...
Plus, news about Tribune Therapeutics and Leap Therapeutics: Humacyte’s $50M...
The Endpoints News Slack chat is back for 2025, and we're starting with a 32-yea...
Decades ago, Amber Salzman remembers feeling like there was nothing she could do...
The Trump administration's threatened tariffs on Europe would be painful for the...
The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Maka...
Stanford researcher Jay Bhattacharya has been confirmed as the new head of the N...
A company that sought to make long-acting forms of commonly used drugs, with bac...
Eisai has slashed 2027 sales projections for its Biogen-partnered Alzheimer’s tr...
Mehmet Oz’s nomination to lead CMS will advance to the full Senate after clearin...
Diagnostics company Revvity will sequence the DNA of newborns to help identify r...
Elon Musk's Department of Government Efficiency has reversed its termination of ...
Illumina on Tuesday added activist investor Keith Meister to its board and named...